Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
MEDBOT-B Snowballs 30% w/ Trading Vol. Surge as Bronchoscopic Surgical Robot UniPath Receives Registration Approval
Recommend 4 Positive 9 Negative 3 |
||||
|
||||
|
MEDBOT-B (02252.HK) opened 6.7% higher today before its gains sharply expanded in the morning session. The stock rose above both the 50-day and 100-day MAs (approx. $23.75 and $24.75 each), and expanded the downward trendline formed since October. It peaked at $27.8, hitting a nearly-2-month high, and last snowballed 30.19% to close at $27.6 near midday. Trading volume surged to 17.6027 million shares, involving $444 million. On Christmas Eve (24 December), MEDBOT-B announced that its self-developed bronchoscopic surgical robot, UniPathTM Electronic Bronchoscopic Surgical Robotic System (UniPath), has been officially approved by China's National Medical Products Administration (NMPA). Brain-computer interface concept stocks listed on the A-share market broadly prospered. XYME (688626.SH) shot up 8.5% at midday, while MEHOW (301363.SZ) and INNOVATIVE MEDICAL (002173.SZ) closed up 5.1%. CENTURY HUATONG (002602.SZ), HANWEI ELECTRONICS (300007.SZ) and APON MEDICAL (300753.SZ) jumped up 2.6-3.8%. AAStocks Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
